SWK Holdings 2022 Life Science Financing Shareholder Presentation

SWK Holdings presents its specialty finance and asset management strategy focused on custom financing solutions for commercial-stage healthcare companies, targeting $5-25mm transactions. The company has deployed $638mm across 45 financings with a portfolio yield of 13.8% and demonstrated 20% IRR on 27 completed exits. The presentation outlines its shareholder value creation strategy emphasizing book value growth and strategic investments in life sciences.